breast cancer epidemiology algeria registry
Showing 1 - 25 of >10,000
Oncology, Epidemiology, Breast Cancer Trial in East Of Algeria, Middle Of Algeria, Ouest Of Algeria/ Oran Region (NIS (Non
Completed
- Oncology
- +2 more
- NIS (Non Interventional Study) observational study
-
East Of Algeria, Algeria
- +2 more
Jun 3, 2022
Oncology & Epidemiology & Lung Cancer Trial in Algiers, Constantine, Oran (NIS observational stud)
Completed
- Oncology & Epidemiology & Lung Cancer
- NIS observational stud
-
Algiers, Algeria
- +2 more
Mar 2, 2022
Breast Cancer, Genetic Disease, BRCA2 Mutation Trial (blood sample for BRCA2 mutation detection)
Not yet recruiting
- Breast Cancer
- +2 more
- blood sample for BRCA2 mutation detection
- (no location specified)
Jun 1, 2023
Patients Who Had Breast Cancer With Dense Breast Tissue
Not yet recruiting
- Breast Cancer
- Questionnaire/Interview
-
Houston, TexasMD Anderson Cancer Center
Nov 7, 2023
International Prospective REgistry on Pre-pectorAl Breast
Not yet recruiting
- Breast Cancer
- pre-pectoral breast reconstruction
- (no location specified)
Apr 4, 2023
Metastatic Breast Cancer, Lobular Breast Carcinoma Trial in San Francisco (Blood Specimen)
Not yet recruiting
- Metastatic Breast Cancer
- Lobular Breast Carcinoma
- Blood Specimen
-
San Francisco, CaliforniaUniversity of California, San Francisco
Jul 19, 2023
CLEAR-B: Cancer Landscape - Early Adjuvant Retrospective
Recruiting
- Breast Cancer
- +2 more
-
Erlangen, GermanyDepartment of Gynecology and Obstetrics, Erlangen University Hos
May 12, 2023
The RISC Registry--Risk Informed Screening Registry
Not yet recruiting
- Breast Cancer Risk
- Cancer Risk Screening and Follow up
-
Palo Alto, CaliforniaPHEI--Precision Health Equity Initiative
Apr 28, 2023
Breast Cancer, Cancer of the Breast Trial in Saint Louis (Cryoablation)
Recruiting
- Breast Cancer
- Cancer of the Breast
- Cryoablation
-
Saint Louis, MissouriWashington University School of Medicine
Aug 2, 2023
Breast Cancer Recurrent Trial
Not yet recruiting
- Breast Cancer Recurrent
- (no location specified)
Jan 12, 2023
Pyrotinib Plus Capecitabine for Adjuvant Treatment of HER2
Recruiting
- HER2-positive Breast Cancer
- Early-stage Breast Cancer
- pyrotinib combined with Capecitabine
- treatment of physician's choice
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Sep 6, 2023
Tumor Biopsy in Creating Research Tissue Registry in
Recruiting
- Inflammatory Breast Carcinoma
- +2 more
- Biospecimen Collection
- +3 more
-
Houston, Texas
- +4 more
Jan 6, 2023
Breast Cancer Trial in Dallas
Enrolling by invitation
- Breast Cancer
-
Dallas, TexasSusan G. Komen
Dec 8, 2022
Epidemiology of TNBC in Asyut Clinical Oncology Department
Not yet recruiting
- Breast Cancer
- (no location specified)
Oct 15, 2022
Breast Abnormality Diagnosis Trial in Arnhem, Groningen, Hengelo (Imagio OA/US)
Enrolling by invitation
- Breast Abnormality Diagnosis
- Imagio OA/US
-
Arnhem, Netherlands
- +2 more
Jan 19, 2023
MRI Background Parenchymal Enhancement asRisk Factor for Breast
Active, not recruiting
- Breast Cancer
-
Basking Ridge, New Jersey
- +6 more
Jul 20, 2022
Breast Cancer Trial in Albuquerque
Active, not recruiting
- Breast Cancer
-
Albuquerque, New MexicoUniversity of New Mexico Comprehensive Cancer Center
Apr 21, 2022
DESTINY Breast Respond HER2-low Europe
Not yet recruiting
- Unresectable Breast Cancer
- +2 more
- Trastuzumab deruxtecan
- (no location specified)
Jul 6, 2023
InheriteD brEast caNcer iTalian regIsTrY A
Recruiting
- Breast Cancer
-
Aviano, Pordenone, Italy
- +11 more
Apr 26, 2023
Toxicities of Salvage Treatment in Locoregionally Recurrent
Not yet recruiting
- Breast Cancer
- Salvage treatment (surgery and/or radiation therapy)
-
Seoul, Korea, Republic ofSamsung Medical Center
Jul 5, 2023
Cancer Related Cardiovascular Toxicity Trial in Italy, North Macedonia, Serbia (Prospective validation of the HFA-ICOS risk
Not yet recruiting
- Cancer Related Cardiovascular Toxicity
- Prospective validation of the HFA-ICOS risk score in a subset of subjects with newly diagnosed breast cancer and undergoing treatment with anthracyclines analogues with or without radiotherapy
-
Bologna, Italy
- +4 more
Oct 11, 2023
Human Epidermal Growth Factor Receptor 2-Positive Unresectable
Active, not recruiting
- Metastatic Breast Cancer
- Locally Advanced Breast Cancer
-
Athens, Greece
- +1 more
Jun 20, 2022
Lung Cancer, Lung Infection, Breast Cancer Trial in Chapel Hill
Recruiting
- Lung Cancer
- +4 more
-
Chapel Hill, North CarolinaUNC Lingeberger Comprehensive Cancer Center
Nov 9, 2022
Radiotherapy Side Effect Trial in Seoul (Hypofractionated radiation therapy)
Recruiting
- Radiotherapy Side Effect
- Hypofractionated radiation therapy
-
Seoul, Korea, Republic ofSamsung Medical Center
Mar 7, 2023
Breast Cancer Trial
Completed
- Breast Cancer
- (no location specified)
Feb 23, 2022